Further, Gpx deficiency leads to cancer predisposition [57] and in vivo sensitivity to oxidant-inducing agents is well documented for mice lacking selenocysteine-containing proteins such as Gpx1 and Gpx4 [58–60]. Here, GPX4 is linked to cancer.